Search Results
Sep 09, 2026, 11:18 ET Feeding Mice Fewer Calories Reduces DNA Mutations
Gilad D. Evrony, MD, PhD, a core member of the
More news about: NYU Langone Health System
Sep 09, 2026, 11:02 ET Two Independent Research Teams Converge on Novel Immune Checkpoint PLA2G2D as a Path to Overcome Anti-PD-1 Resistance in Cancer
Dammeijer, MD, PhD, Erasmus MC. "When we began this work, we were asking a straightforward question: how do cancer cells block effective anti-tumor immune responses where they are first generated, in the lymph node? The answer, unexpectedly, kept pointing to PLA2G2D."Ralph Stadhouders, PhD, Erasmus
More news about: Apeximmune
Sep 09, 2026, 11:00 ET More Than 400 Health Care Professionals to Gather in Illinois to Improve Patient Care
Catherine R. Lucey, MD, MACP, Executive Vice Chancellor and Provost, University of California, San Francisco Zirui Song, MD, PhD, Associate Professor of Health Care Policy and Medicine, Harvard Medical School and Massachusetts General Hospital; Member, Massachusetts
More news about: American Board of Medical Specialties
Sep 09, 2026, 10:06 ET Cronus Market Intelligence Publishes RegimeSignal's Accuracy Signal by Signal -- Bear 86%, Correction 84%, Pullback 83%, Recovery 82%, Averaging 84% Across the Full S&P 500 Cycle
historical upper bound and the signal the PhD reviews qualified.RegimeSignal also screens individual stocks, sectors and global indexes, and issues a report on any name covered. Those layers are coverage; the 84% covers the four S&P 500 signals only.The PhD reviews reproduced the bear, pullback
More news about: Cronus Market Intelligence, LLC
Sep 09, 2026, 09:04 ET Onix Expands Its Trusted AI Platform With $5 Million USD Pre-Seed Round
Elissa Epel, PhD; Nicole Beurkens, PhD;
More news about: Onix
Sep 09, 2026, 09:00 ET Mighty Therapeutics Initiates IND-Enabling Studies of MYTX-255: a Mitochondrial-Targeted Therapeutic Candidate
mitochondria-targeted therapeutic toward the clinic, furthering our pioneering work in mitochondrial medicine across a range of serious diseases," said David A. Brown, PhD, Chief Scientific Officer at Mighty Therapeutics. "Based on the compelling data we recently presented at the INFORM Annual Meeting, we intend to develop
More news about: Mighty Therapeutics
Sep 09, 2026, 08:50 ET Association of Black Cardiologists Names 2026 Spirit of the Heart Honorees
Barbara A. Hutchinson, MD, PhD, Awards Program Co-Chair and Past ABC Board Chair. "We are honored to celebrate this year's recipients and grateful for the opportunity to bring
More news about: Association of Black Cardiologists
Sep 09, 2026, 08:32 ET Michael J. Fox Receives Lasker~Bloomberg Public Service Award for Transformative Leadership in Parkinson's Research
chronic underinvestment and stalled innovation, Fox helped pioneer an entrepreneurial approach to biomedical philanthropy, assembling an in-house team of PhD-trained scientists and business strategists to learn from patients themselves about their unmet medical needs and fund high-risk, high-reward research
More news about: The Michael J. Fox Foundation for Parkinson's Research
Sep 09, 2026, 08:00 ET Luma Group Successfully Closes LumaBio Fund I at $410 Million
fundamentally reshape medicine as once-distinct scientific disciplines converge and the pace of discovery and translation accelerates," added Themasap Khan, PhD, Co-Founder and Partner of Luma Group. Since its inception in 2023, LumaBio Fund I has invested in companies with the potential to transform medicine,
More news about: Luma Group
Sep 09, 2026, 08:00 ET Parker Institute for Cancer Immunotherapy Names Maria Olson Chief Advancement Officer
fundraising expertise and a deep understanding of what it takes to build lasting relationships with donors and partners," said Dr. Karen E. Knudsen, MBA, PhD, CEO of PICI. "As PICI continues to expand the reach and impact of its scientific network, Maria's leadership will be instrumental in building the philanthropic
More news about: Parker Institute for Cancer Immunotherapy
Sep 09, 2026, 08:00 ET CENTURY LITHIUM FILES MINE PLAN OF OPERATIONS FOR ANGEL ISLAND LITHIUM PROJECT IN NEVADA
delivery.Qualified PersonThe scientific and technical information in this news release was reviewed and approved by William Willoughby, PhD, PE, President and Chief Executive Officer of Century Lithium Corp., who is a Qualified Person as defined by National Instrument 43-101 – Standards of
More news about: Century Lithium Corp.
Sep 09, 2026, 08:00 ET 1cBio and Lee's Pharmaceutical Holdings Limited Enter into Exclusive Licensing Agreement to Develop and Commercialize 1cBio's PARP1 Inhibitor OC-3 for Oncology in Greater China and Southeast Asia
activities."This agreement with Lee's Pharm provides 1cBio a valued China-based drug development and commercialization partner for OC-3," said Andrew Protter, PhD, CEO of 1cBio. "With Lee's Pharm, 1cBio collaborates with a team that has a robust oncology group, strong manufacturing capabilities, and a proven ability
More news about: 1cBio, Inc.
Sep 09, 2026, 07:12 ET Harbour BioMed Partner, Solstice Oncology, announces $225 Million Series A Financing to Advance Porustobart, a Neoadjuvant Immuno-Oncology Therapy
when the tumor is still present, the immune system is still intact, and disease hasn't yet hardened its resistance to treatment," said Caroline Loew, PhD, CEO of Solstice Oncology. "Treating patients early with an immuno-oncology combination therapy like the one we are evaluating in our Phase 2 trial could
More news about: Harbour BioMed
Sep 09, 2026, 07:05 ET Cionic Real-World Evidence Study Examines Quality of Life Across Upper Motor Neuron Conditions
mobility impairments caused by upper motor neuron conditions, yet their experiences are rarely counted in large-scale datasets," said Rebecca Webster, PhD, vice president of clinical operations at Cionic. "Our intention is to build a dataset to advance the understanding of key health-related quality of
More news about: Cionic
Sep 09, 2026, 07:00 ET Matica Biotechnology and Bondwell Technologies Collaborate to Advance Texas Biotech Innovation
company that built it says it works. It gets adopted when a manufacturer runs it on their own equipment and reports what happened," said David Howell, PhD, Chief Executive Officer of Bondwell Technologies."Having that development expertise nearby is what makes it practical to build this technology in Texas."Over
More news about: Matica Biotechnology, Inc.
Sep 09, 2026, 06:00 ET The Farmer's Dog Named the NFL's First-Ever Official Pet Food Partner
processed meal plans designed to help dogs live longer, healthier lives. Our on-staff team of Board-Certified Veterinary Nutritionists®, PhD nutritionists, and veterinarians work to develop recipes packed with the nutrients dogs need, while avoiding the downsides of excess processing. Every
More news about: The Farmer's Dog
Sep 09, 2026, 02:00 ET Just - Evotec Biologics Advances U.S. Department of War Antibodies Against Orthopoxvirus into Phase 1 Clinical Studies
prophylactic therapy intended to help protect warfighters who may face an elevated risk of exposure to biological threats.Linda Zuckerman, PhD, EVP Global Head of Just – Evotec Biologics, said:"This program exemplifies the power of our integrated continuous manufacturing platform
More news about: Evotec SE
Sep 09, 2026, 00:03 ET LinqAlpha and KOSCOM Sign MOU to Expand Access to Korean Market Data for Global Investors
Intelligence Layer for global financial markets. Founded by a team including former Goldman Sachs investment professionals, an MIT computer science PhD and UC Berkeley MFE alumni, LinqAlpha serves more than 70 financial institutions across the United States, Europe and Asia.About KOSCOMEstablished
More news about: LinqAlpha
Sep 08, 2026, 11:49 ET Groundbreaking ARUP Research Clarifies Clinical Value of Atypical Cell-Free DNA Screening Results
"No one has conducted a study as large as this on atypical findings," said Katie Rudd, PhD, FACMG, ARUP medical director of Cytogenetics and Genomic Microarray. She and her peers analyzed more than 10 years of data and more than 200 cases with
More news about: ARUP Laboratories
Sep 08, 2026, 11:05 ET Prezent Vivo Appoints Medical Communications Leader Alice Choi as Chief Operating Officer
makes her a powerful force in expanding Prezent Vivo's presence in the market."Alice began her career in academia, earning a master's degree and PhD before transitioning into medical communications. She built her career across organizations including McCann Health and the Omnicom network, with experience
More news about: Prezent
Sep 08, 2026, 10:58 ET Clinical Science Update | New Clinical Evidence for ClotChek™
decision making in time-sensitive patient scenarios such as major bleeding, acute ischemic stroke, trauma, and emergent surgery," said Sasha Bakhru, PhD, co-author and CEO of Perosphere.Importantly, ClotChek provides a pharmacodynamic measurement of a patient's coagulation status in whole blood,
More news about: Perosphere Technologies Inc.
Sep 08, 2026, 10:05 ET Twenty Five Years After 9/11, Two-Thirds of Middle East Studies Professors Say American Academia Has Since Generated Cover to Ideologies and Regimes Hostile for the U.S.
types or career lengths."We've long read reports in the press alerting us to various biases in American academia," said Asaf Romirowsky, PhD, ASMEA's Executive Director. "Our most recent survey proves that the concerns aren't merely anecdotal, and that we're facing a pandemic of ideological
More news about: Association for the Study of the Middle East and Africa (ASMEA)
Sep 08, 2026, 09:52 ET Nootropics Depot Launches SulfoMax, the World's Highest Sulforaphane Supplement
(COAs), and lab testing results available on every product page. In addition, they have formed a Scientific Advisory Board with board certified doctors, PhD researchers, and botanists to ensure that consumers can trust that scientific rigor is being upheld in everything they do. Nootropics Depot's newly redesigned
More news about: Nootropics Depot
Sep 08, 2026, 09:00 ET Alliant University Invites Prospective Students to Explore Graduate Programs Through Virtual Fall Events
PTClinical Psychology PhD: 12:30–1:30 p.m. PTMarital and Family Therapy MA and PhD: 3:30–4:30 p.m. PTSan Diego Campus — Wednesday, September 16Clinical Psychology PsyD: 11 a.m.–12 p.m. PTClinical Psychology PhD: 12:30–1:30 p.m. PTMarital
More news about: Alliant University
Sep 08, 2026, 09:00 ET The V Foundation for Cancer Research Awards $1.8 Million in Grants to Children's Hospital of Philadelphia Researchers
Andrei Thomas-Tikhonenko, PhD, Chief of the
More news about: Children's Hospital of Philadelphia